Department of Health - Abu Dhabi and Opus Genetics Announce Collaboration to Advance Ground-Breaking Gene Therapy Research for Inherited Retinal Diseases prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
New Preliminary Clinical Data on Potential of Opus AAV-based Gene Therapy for Rare Inherited Retinal Disease to be Presented at the American Academy of Ophthalmology Annual Conference 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Triangle Venture Day, hosted at Apella by Alexandria at the Alexandria Center for Advanced Technologies campus, proved to be one of promise of the Triangle’s growing innovation ecosystem, optimism for high-impact science, and enthusiasm for local collaboration.
Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, has raised an additional $4.5 million in funding from investors.
Opus Genetics, a Durham-based company developing drugs to treat retinal diseases has raised an additional $4.5 million from investors. Here's how the CEO plans to invest the money.